Promising new cancer therapy appears to be extremely potent against tuberculosis

A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB).

Former Regenxbio leaders take rare disease gene therapies to startup with $15M

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 28, 2024

UQ study reveals 25% drop in child maltreatment in communities using Triple P Parenting Program

University of Queensland research shows child maltreatment cases decreased in socially disadvantaged communities that participated in positive parenting programs.

July 31, 2024

Exclusive: Inspired by Spinraza, startup raises $25M for cancer drug targets created by alternative RNA splicing

Envisagenics, a startup founded by scientists from Cold Spring Harbor Laboratory, has raised a $25 million series B round to develop drugs for cancer and

June 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.